Public Company News

ATRenew Highly Commended by Treasury Today Group's Adam Smith Awards Asia 2021

SHANGHAI, Oct. 20, 2021 /PRNewswire/ -- AiHuiShou International Co. Ltd. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, was highly commended by Treasury Today Group's Adam Smith Awards Asia 2021 (th...

2021-10-20 19:00 2455

China Yuchai Forms Joint Venture in Beijing to Develop Fuel Cell Powertrain Systems

SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") a leading manufacturer and distributor of engines for on- and off-road applications inChina through its main operating subsidiary, Guangxi Yuchai Machinery Company Limited (...

2021-10-20 18:30 2677

FinVolution Group Raises Guidance for Full Year 2021

SHANGHAI, Oct. 20, 2021 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform inChina, today announced that based on its current assessment of operational and market conditions, the Company has raised its total transaction volume guidance for...

2021-10-20 12:30 3886

SK hynix Announces Development of HBM3 DRAM

SEOUL, South Korea, Oct. 19, 2021 /PRNewswire/ -- SK hynix Inc. (or "the Company",www.skhynix.com ) announced that it has become the first in the industry to successfully develop the High Bandwidth Memory 3, the world's best-performing DRAM.

2021-10-20 08:00 3509

Japanese Alternative Meat venture Next Meats announces upgrade of signature barbecue meat: Next Yakiniku Short-rib 2.0

TOKYO, Oct. 19, 2021 /PRNewswire/ -- Next Meats Co. Ltd, a Tokyo-based food-tech venture known for developing the world's first plant-based barbecue meats, the "Next Yakiniku" series, just announced the launch of their newest version of the Short-Rib style product: the Next Yakiniku Short-Rib 2.0...

2021-10-20 07:49 3741

Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China

* China Phase I study of BBT-401 had its first subject dosed in Chengdu, China * The company seeks to accelerate its business development activities with Daewoong, their partner for the development and commercialization of BBT-401 in 22 Asian countries SEONGNAM, South Korea and CHENGDU, China, ...

2021-10-20 07:00 2098

Amcor to Report First Quarter 2022 Results

ZURICH, Switzerland, Oct. 19, 2021 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its results for the three months ended30 September 2021 after the US market closes on Tuesday2 November 2021.   A conference call and webcast to discuss the results will be held at 5.30pm US Eastern...

2021-10-20 05:36 4658

Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program

- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology c...

2021-10-20 05:08 2464

China Liberal Announces Results of Annual General Meeting of Shareholders for Fiscal Year 2021

BEIJING, Oct. 19, 2021 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", the "Company", or "we"), a China-based company that provides smart campus solutions and other educational services, today announced the results of the Company's 2021 Annual General Mee...

2021-10-19 21:00 1917

E-Home Household Service Holdings Limited Dissolves the VIE Structure

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that its indirectly wholly owned Chinese subsidiary, E-Home Household Service Technology Co., Ltd....

2021-10-19 20:30 3853

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been ...

2021-10-19 20:00 2117

Pingtan Marine Enterprise Receives Nasdaq's Determination Letter

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME), ("Pingtan," or the "Company"), a fishing company based in the People's Republic of China, announced today that it received a determination notice letter datedOctober 13, 2021 (the "Determination Notice") fr...

2021-10-19 20:00 4262

Zenix Enters into Definitive Agreement for "Going Private" Transaction

BEIJING, Oct. 19, 2021 /PRNewswire/ -- China Zenix Auto International Limited (OTC: ZXAIY) (the "Company"), one of the largest commercial vehicle wheel manufacturers inChina in both the aftermarket and OEM market by sales volume, today announced that it has entered into an Agreement and Plan of M...

2021-10-19 19:33 4182

36Kr Announces Short-Form Video Marketing Collaboration with Intel

BEIJING, Oct. 19, 2021 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants inChina, today announced that the Company has provided customized short-form video advertising solutions for ...

2021-10-19 19:00 2199

Carrier Acquires Cavius, an Innovative Residential Alarm Company

Strategic acquisition expands Carrier's Healthy Homes offering and strengthens its interconnected Fire & Security portfolio PALM BEACH GARDENS, Fla., Oct. 19, 2021 /PRNewswire/ -- Carrier Global Corporation (NYSE:CARR) the leading global provider of healthy, safe, sustainable and intelligent bui...

2021-10-19 18:55 4359

Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment ...

2021-10-19 17:52 2535

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its licensees, GBS Inc (Nasdaq: GBS); a life sciences company operating in theAsia Pacific region, under lice...

2021-10-19 15:01 2377

Tingo, Inc. Announces Submission of Listing Application to the New York Stock Exchange

Company Seeks to Enhance Profile and Investor Reach NEW YORK, Oct. 19, 2021 /PRNewswire/ -- Tingo, Inc., OTC Markets (IWBB) ("Tingo" or the "Company") announced today that it has submitted an application to list its shares for trading with the New York Stock Exchange (NYSE). The application to t...

2021-10-19 14:25 3140

InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China

BEIJING, Oct. 19, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval from the NMPA for itsSHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189, which is the company's...

2021-10-19 12:56 2362

Shikigaku Co., Ltd. (7049, TSE Mothers) performance for the first six months ended august 31, 2021

TOKYO, Oct. 18, 2021 /PRNewswire/ -- Both sales and profit grew substantially during the six months endedAugust 31, 2021. Results were strong in the core Consulting business, and the Company reported large growth in performance from management consulting services and platform services. Summary o...

2021-10-19 10:10 2321
1 ... 705706707708709710711 ... 766